What's new

Human medicines European public assessment report (EPAR): Vyndaqel, tafamidis, Date of authorisation: 16/11/2011, Revision: 30, Status: Authorised

Human medicines European public assessment report (EPAR): Vyndaqel, tafamidis, Date of authorisation: 16/11/2011, Revision: 30, Status: Authorised

Feb 18, 2025 - 15:46
 0
Human medicines European public assessment report (EPAR): Vyndaqel, tafamidis, Date of authorisation: 16/11/2011, Revision: 30, Status: Authorised
Human medicines European public assessment report (EPAR): Vyndaqel, tafamidis, Date of authorisation: 16/11/2011, Revision: 30, Status: Authorised
Read More

Tags:

Previous Article

Nvidia discloses investment into robotaxi firm WeRide

Next Article

Human medicines European public assessment report (EPAR): GoResp Digihaler (prev...

Related Posts

Template for assessment report for the development of European Union herbal monographs and list entries

Template for assessment report for the development of E...

Feb 17, 2025  0

Cancer Medicines Forum: December 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, 16 December 2024

Cancer Medicines Forum: December 2024, Online, European...

Mar 11, 2025  0

Human medicines European public assessment report (EPAR): Tarceva, erlotinib, Date of authorisation: 19/09/2005, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 5, 2025  0